Steven M Dubinett

Title(s)Dean, Deans Office-School Of Medicin
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor, Medicine

    Title(s)Professor, Pathology and Laboratory Medicine

    Title(s)Professor, Molecular and Medical Pharmacology


    Collapse Biography 
    Collapse Education and Training
    Rutgers New Jersey Medical School, Newark, New JerseyM.D.06/1980Medicine
    University Hospital, Newark, New JerseyInternship06/1981Internal Medicine
    University of California, Los Angeles, Los Angeles, CaliforniaResidency06/1983Internal Medicine
    University of California, Los Angeles, Los Angeles, CaliforniaChief Resident06/1984Internal Medicine
    Massachusetts General Hospital, Boston, MassachusettsFellow06/1988Pulmonary Medicine
    Harvard Medical School, Boston, MassachuettsResident Fellow06/1988Tumor Immunology
    Collapse Awards and Honors
    U.S. Department of Veterans Affairs2019William S. Middleton Award
    American Lung Association20192019 Lung Force Honoree
    201446th Annual Harold J. Jeghers Memorial Lecture
    Barlow Respiratory Hospital2014Medical Excellence Award
    Uniting Against Lung Cancer2012Continued Support and Dedication to their Mission and the Advancement of the Field of Lung Cancer
    FDA Cellular, Tissue and Gene Therapies Advisory Committee 2011Chair
    Chinese Academy of Sciences in Beijing and Shanghai with Chancellor Gene Block2011UCLA rep. for research presentations/signing ceremonies for translational medicine agreements
    Meharry Medical College/Vanderbilt Ingram Cancer Center2009The Philip J. Browning Memorial Lecture
    American Thoracic Society 2008American Thoracic Society Recognition Award for Scientific Accomplishments
    1999The Stanley Blatt Award for Lung Cancer Research
    American Lung Association1996Career Investigator Award
    1995Helen Neufeld Research Career Development Award (Stop Cancer Award)
    Jonsson Comprehensive Cancer Center1994Dwyer Award
    UC Tobacco-Related Disease Research Program1990New Investigator Award
    Southern California Pulmonary Research Conference1989Young Investigator Award
    American College of Chest Physicians1987Cecile Lehman Mayer Research Award

    Collapse Overview 
    Collapse Overview
    Steven M. Dubinett is director of the UCLA Clinical & Translational Science Institute, Associate Vice Chancellor and Senior Associate Dean for Translational Research. He oversees the translation of UCLA biomedical discoveries into medical products and health interventions and is responsible for the efficient integration of the research infrastructure through the CTSI. He is former Chair of the Executive Committee of UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), which integrates clinical and translational research across the University of California. Dr. Dubinett has extensive experience in translational investigation, academic administration, mentorship and peer review. He has trained more than 45-graduate students, post-doctoral fellows and junior faculty, nearly all of whom have continued in academic or industry research careers. Building on original discoveries relevant to inflammation and immunity in lung cancer, he developed a translational research program, which utilizes these laboratory-based discoveries in the translational and clinical environment. As a NCI Translational Research Working Group member, he participated in designing pathways to clinical goals. He previously served as Director for Biomarker Development for the American College of Surgeons Oncology Group, directing biospecimen utilization in the context of clinical trials. Dr. Dubinett serves as the Chair of the Research Evaluation Panel for biospecimen utilization for the American College of Radiology Imaging Network/ National Lung Screening Trial. He previously chaired the FDA Cellular, Tissue & Gene Therapies Advisory Committee and serves on the NCI Thoracic Malignancy Steering Committee as a Translational Science.

    Collapse Research 
    Collapse Research Activities and Funding
    Exosome-mediated mechanisms of metastatic disease in non-small cell lung cancer
    NIH I01BX004717Oct 1, 2020 - Sep 30, 2024
    Role: Principal Investigator
    Exosome-mediated mechanisms of metastatic disease in non-small cell lung cancer
    Veteran's Administration I01BX004717Oct 1, 2020 - Sep 30, 2024
    Role: Principal Investigator
    Pulmonary and Critical Care Medicine Training Program
    NIH/NHLBI T32HL072752May 1, 2020 - Apr 30, 2025
    Role: Principal Investigator
    Early detection of metastatic disease in US Veterans following surgery for early stage lung cancer
    NIH I01CX002005Apr 1, 2020 - Mar 31, 2023
    Role: Principal Investigator
    In situ vaccination of CXCL9/10-secreting dendritic cells combined with anti-PD-1 for NSCLC
    UC Tobacco-Related Disease Research Program Predoctoral Fellowship AwardSep 2, 2019 - Aug 31, 2021
    Role: Mentor
    Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data
    NIH R01CA246329Sep 1, 2019 - Aug 31, 2023
    Role: Principal Investigator
    The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
    NIH U2CCA233238Sep 30, 2018 - Jun 30, 2023
    Role: Principal Investigator
    A Phase I trial of intratumoral administration of CCL21-gene modified human monocyte-derived dendritic cells (DC) combined with pembrolizumab
    CIRM CLIN2-10784Jul 1, 2018 - Jun 30, 2023
    Role: Principal Investigator
    EFIRM-Liquid Biopsy (eLB): Early Lung Cancer Assessment by miRNA and ctDNA Detection
    NIH/NCI U01CA233370Jul 1, 2018 - Jun 30, 2023
    Role: Other Significant Contributor
    Tumor Immunology Institutional Training Grant
    NIH/NCI T32CA009120Apr 1, 2018 - Mar 31, 2023
    Role: Principal Investigator
    Immune reactivity across the spectrum of disease in lung adenocarcinoma
    UC Tobacco-Related Disease Research Program 27IR-0036Apr 1, 2018 - Mar 31, 2021
    Role: Other Significant Contributor
    Intercept Lung Cancer Through Immune, Imaging, & Molecular Evaluation (InTIME)
    SU2C-AACR SU2C-AACR-DT23-17Mar 1, 2018 - Feb 28, 2022
    Role: Principal Investigator
    Molecular and imaging biomarkers for early lung cancer detection in the setting of indeterminate pulmonary nodules
    NIH/NCI 1R01CA21036001Sep 23, 2016 - Aug 31, 2021
    Role: Other Significant Contributor
    The Boston University-UCLA Lung Cancer Biomarker Development Lab
    NIH U01CA214182Sep 20, 2016 - Mar 31, 2022
    Role: Principal Investigator
    A model for predicting response to PD-1 inhibitors in NSCLC
    NIH/NCI 1R01CA208403Sep 1, 2016 - Aug 31, 2021
    Role: Other Significant Contributor
    Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
    NIH/NCI R01CA208642Aug 1, 2016 - Jul 31, 2021
    Role: Other Significant Contributor
    UCLA Clinical Translational Science Institute
    NIH UL1TR001881Jul 1, 2016 - May 31, 2022
    Role: Principal Investigator
    Institutional Career Development Core
    NIH KL2TR001882Jul 1, 2016 - May 31, 2021
    Role: Principal Investigator
    NRSA Training Core
    NIH TL1TR001883Jul 1, 2016 - May 31, 2021
    Role: Principal Investigator
    Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer
    NIH U01CA196408Sep 16, 2015 - Aug 31, 2022
    Role: Principal Investigator
    The University of California Center for Accelerated Innovation
    NIH/NHLBI U54HL119893Sep 26, 2013 - Jul 31, 2021
    Role: Other Significant Contributor
    Clinically Actionable Neoantigens in Non-Small Cell Lung Cancer
    NIH I01CX000345Apr 1, 2012 - Sep 30, 2021
    Role: Principal Investigator
    UCLA Clinical and Translational Science Institute
    NIH KL2TR000122Jun 1, 2011 - Aug 31, 2016
    Role: Principal Investigator
    UCLA Clinical and Translational Science Institute
    NIH TL1TR000121Jun 1, 2011 - Aug 31, 2016
    Role: Principal Investigator
    UCLA Clinical and Translational Science Institute
    NIH UL1TR000124Jun 1, 2011 - Aug 31, 2016
    Role: Principal Investigator
    UCLA Clinical and Translational Science Institute
    NIH KL2RR033185Jun 1, 2011 - Feb 29, 2016
    Role: Principal Investigator
    UCLA Clinical and Translational Science Institute
    NIH TL1RR033175Jun 1, 2011 - Feb 29, 2016
    Role: Principal Investigator
    UCLA Clinical and Translational Science Institute
    NIH UL1RR033176Jun 1, 2011 - Feb 29, 2016
    Role: Principal Investigator
    The UCLA - Boston University Lung Cancer Biomarker Development Laboratory
    NIH U01CA152751Sep 24, 2010 - Jun 30, 2016
    Role: Principal Investigator
    Cell Motility in the Pathogenesis of Lung Cancer
    NIH I01BX000359Apr 1, 2009 - Sep 30, 2018
    Role: Principal Investigator
    Novel COX-2 and PGE2-dependent pathways in lung cancer
    NIH R01CA111851Mar 17, 2006 - Jan 31, 2013
    Role: Principal Investigator
    A Phase I Trial of CCL-21 Gene Modified DC in NSCLC
    NIH R21CA105705Sep 30, 2003 - May 31, 2010
    Role: Principal Investigator
    UCLA Pulmonary and Critical Care Medicine Training Program
    NIH T32HL072752Jul 1, 2003 - Apr 30, 2025
    Role: Principal Investigator
    UCLA SPORE IN LUNG CANCER
    NIH P50CA090388Jun 1, 2001 - Jun 30, 2010
    Role: Principal Investigator
    GENETIC IMMUNOTHERAPY FOR LUNG CANCER
    NIH R01CA085686Jan 1, 2001 - Dec 31, 2006
    Role: Principal Investigator
    FUNCTION AND REGULATION OF IL 10 IN LUNG CANCER
    NIH R01CA071818Apr 4, 1997 - Mar 31, 2002
    Role: Principal Investigator
    UCLA Tumor Immunology Institutional Traning Grant
    NIH T32CA009120Jul 1, 1980 - Mar 31, 2023
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Expression of Concern: Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity. Cancer Discov. 2024 07 01; 14(7):1357. Hong A, Piva M, Liu S, Hugo W, Lomeli SH, Zoete V, Randolph CE, Yang Z, Wang Y, Lee JJ, Lo SJ, Sun L, Vega-Crespo A, Garcia AJ, Shackelford DB, Dubinett SM, Scumpia PO, Byrum SD, Tackett AJ, Donahue TR, Michielin O, Holmen SL, Ribas A, Moriceau G, Lo RS. PMID: 38946326.
      View in: PubMed   Mentions:
    2. Single-stranded pre-methylated 5mC adapters uncover the methylation profile of plasma ultrashort Single-stranded cell-free DNA. Nucleic Acids Res. 2024 Jun 24; 52(11):e50. Cheng JC, Swarup N, Morselli M, Huang WL, Aziz M, Caggiano C, Kordi M, Patel AA, Chia D, Kim Y, Li F, Wei F, Zaitlen N, Krysan K, Dubinett S, Pellegrini M, Wong DTW. PMID: 38797520; PMCID: PMC11194076.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Noninvasive lung cancer subtype classification using tumor-derived signatures and cfDNA methylome. Cancer Res Commun. 2024 Jun 10. Li S, Li W, Liu B, Krysan K, Dubinett SM. PMID: 38856716.
      View in: PubMed   Mentions:    Fields:    
    4. Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity. Cell Rep. 2024 Jun 02; 43(6):114289. Purbey PK, Seo J, Paul MK, Iwamoto KS, Daly AE, Feng AC, Champhekar AS, Langerman J, Campbell KM, Schaue D, McBride WH, Dubinett SM, Ribas A, Smale ST, Scumpia PO. PMID: 38833371.
      View in: PubMed   Mentions:    Fields:    
    5. The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion. Res Sq. 2024 May 15. Hu X, Zhu B, Vokes N, Fujimoto J, Rojas Alvarez FR, Heeke S, Moreira AL, Solis LM, Haymaker C, Velcheti V, Sterman DH, Pass HI, Cheng C, Lee JJ, Zhang J, Wei Z, Wu J, Le X, Ostrin E, Toumazis I, Gibbons D, Su D, Fukuoka J, Antonoff MB, Gerber DE, Li C, Kadara H, Wang L, Davis M, Heymach JV, Hannash S, Wistuba I, Dubinett S, Alexandrov L, Lippman S, Spira A, Futreal AP, Reuben A, Zhang J. PMID: 38798564; PMCID: PMC11118701.
      View in: PubMed   Mentions:
    6. Author Correction: Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer. Nat Commun. 2024 May 01; 15(1):3693. Stackpole ML, Zeng W, Li S, Liu CC, Zhou Y, He S, Yeh A, Wang Z, Sun F, Li Q, Yuan Z, Yildirim A, Chen PJ, Winograd P, Tran B, Lee YT, Li PS, Noor Z, Yokomizo M, Ahuja P, Zhu Y, Tseng HR, Tomlinson JS, Garon E, French S, Magyar CE, Dry S, Lajonchere C, Geschwind D, Choi G, Saab S, Alber F, Wong WH, Dubinett SM, Aberle DR, Agopian V, Han SB, Ni X, Li W, Zhou XJ. PMID: 38693151; PMCID: PMC11063198.
      View in: PubMed   Mentions:    Fields:    
    7. Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature. 2024 Apr; 628(8006):E1. Han G, Sinjab A, Rahal Z, Lynch AM, Treekitkarnmongkol W, Liu Y, Serrano AG, Feng J, Liang K, Khan K, Lu W, Hernandez SD, Liu Y, Cao X, Dai E, Pei G, Hu J, Abaya C, Gomez-Bolanos LI, Peng F, Chen M, Parra ER, Cascone T, Sepesi B, Moghaddam SJ, Scheet P, Negrao MV, Heymach JV, Li M, Dubinett SM, Stevenson CS, Spira AE, Fujimoto J, Solis LM, Wistuba II, Chen J, Wang L, Kadara H. PMID: 38499683; PMCID: PMC10990920.
      View in: PubMed   Mentions:    Fields:    
    8. CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer. Cell Rep Med. 2024 Mar 19; 101479. Lim RJ, Salehi-Rad R, Tran LM, Oh MS, Dumitras C, Crosson WP, Li R, Patel TS, Man S, Yean CE, Abascal J, Huang Z, Ong SL, Krysan K, Dubinett SM, Liu B. PMID: 38518770.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    9. An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature. 2024 Mar; 627(8004):656-663. Han G, Sinjab A, Rahal Z, Lynch AM, Treekitkarnmongkol W, Liu Y, Serrano AG, Feng J, Liang K, Khan K, Lu W, Hernandez SD, Liu Y, Cao X, Dai E, Pei G, Hu J, Abaya C, Gomez-Bolanos LI, Peng F, Chen M, Parra ER, Cascone T, Sepesi B, Moghaddam SJ, Scheet P, Negrao MV, Heymach JV, Li M, Dubinett SM, Stevenson CS, Spira AE, Fujimoto J, Solis LM, Wistuba II, Chen J, Wang L, Kadara H. PMID: 38418883; PMCID: PMC10954546.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma. Cancer Res. 2024 01 16; 84(2):305-327. Saggese P, Pandey A, Alcaraz M, Fung E, Hall A, Yanagawa J, Rodriguez EF, Grogan TR, Giurato G, Nassa G, Salvati A, Shirihai OS, Weisz A, Dubinett SM, Scafoglio C. PMID: 37934116; PMCID: PMC10790128.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    11. Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment. Cells. 2023 10 04; 12(19). Abascal J, Oh MS, Liclican EL, Dubinett SM, Salehi-Rad R, Liu B. PMID: 37830618; PMCID: PMC10571973.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    12. Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma. Cancer Res. 2023 10 02; 83(19):3305-3319. Yanagawa J, Tran LM, Salehi-Rad R, Lim RJ, Dumitras C, Fung E, Wallace WD, Prosper AE, Fishbein G, Shea C, Hong R, Kahangi B, Deng JJ, Gower AC, Liu B, Campbell JD, Mazzilli SA, Beane JE, Kadara H, Lenburg ME, Spira AE, Aberle DR, Krysan K, Dubinett SM. PMID: 37477508; PMCID: PMC10544016.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity. J Immunother Cancer. 2023 09; 11(9). Salehi-Rad R, Lim RJ, Du Y, Tran LM, Li R, Ong SL, Ling Huang Z, Dumitras C, Zhang T, Park SJ, Crosson W, Kahangi B, Abascal J, Seet C, Oh M, Shabihkhani M, Paul M, Krysan K, Lisberg AE, Garon EB, Liu B, Dubinett SM. PMID: 37730274; PMCID: PMC10510892.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    14. Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring. Proc Natl Acad Sci U S A. 2023 07 11; 120(28):e2305236120. Li S, Zeng W, Ni X, Liu Q, Li W, Stackpole ML, Zhou Y, Gower A, Krysan K, Ahuja P, Lu DS, Raman SS, Hsu W, Aberle DR, Magyar CE, French SW, Han SB, Garon EB, Agopian VG, Wong WH, Dubinett SM, Zhou XJ. PMID: 37399400; PMCID: PMC10334733.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    15. Multi-organ landscape of therapy-resistant melanoma. Nat Med. 2023 05; 29(5):1123-1134. Liu S, Dharanipragada P, Lomeli SH, Wang Y, Zhang X, Yang Z, Lim RJ, Dumitras C, Scumpia PO, Dubinett SM, Moriceau G, Johnson DB, Moschos SJ, Lo RS. PMID: 37106167; PMCID: PMC10202813.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    16. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduct Target Ther. 2023 04 17; 8(1):155. Hu J, Tan P, Ishihara M, Bayley NA, Schokrpur S, Reynoso JG, Zhang Y, Lim RJ, Dumitras C, Yang L, Dubinett SM, Jat PS, Van Snick J, Huang J, Chin AI, Prins RM, Graeber TG, Xu H, Wu L. PMID: 37069149; PMCID: PMC10110583.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma. JTO Clin Res Rep. 2023 Sep; 4(9):100504. Kammer MN, Mori H, Rowe DJ, Chen SC, Vasiukov G, Atwater T, Senosain MF, Antic S, Zou Y, Chen H, Peikert T, Deppen S, Grogan EL, Massion PP, Dubinett S, Lenburg M, Borowsky A, Maldonado F. PMID: 37674811; PMCID: PMC10477685.
      View in: PubMed   Mentions:
    18. Spatial mapping of mitochondrial networks and bioenergetics in lung cancer. Nature. 2023 03; 615(7953):712-719. Han M, Bushong EA, Segawa M, Tiard A, Wong A, Brady MR, Momcilovic M, Wolf DM, Zhang R, Petcherski A, Madany M, Xu S, Lee JT, Poyurovsky MV, Olszewski K, Holloway T, Gomez A, John MS, Dubinett SM, Koehler CM, Shirihai OS, Stiles L, Lisberg A, Soatto S, Sadeghi S, Ellisman MH, Shackelford DB. PMID: 36922590; PMCID: PMC10033418.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    19. Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma. bioRxiv. 2023 Feb 01. Saggese P, Pandey A, Fung E, Hall A, Yanagawa J, Rodriguez EF, Grogan TR, Giurato G, Nassa G, Salvati A, Weisz A, Dubinett SM, Scafoglio C. PMID: 36778362; PMCID: PMC9915520.
      View in: PubMed   Mentions:
    20. The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma. Cancer Discov. 2022 11 02; 12(11):2626-2645. Hao D, Han G, Sinjab A, Gomez-Bolanos LI, Lazcano R, Serrano A, Hernandez SD, Dai E, Cao X, Hu J, Dang M, Wang R, Chu Y, Song X, Zhang J, Parra ER, Wargo JA, Swisher SG, Cascone T, Sepesi B, Futreal AP, Li M, Dubinett SM, Fujimoto J, Solis Soto LM, Wistuba II, Stevenson CS, Spira A, Shalapour S, Kadara H, Wang L. PMID: 36098652; PMCID: PMC9633381.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    21. Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer. Nat Commun. 2022 09 29; 13(1):5566. Stackpole ML, Zeng W, Li S, Liu CC, Zhou Y, He S, Yeh A, Wang Z, Sun F, Li Q, Yuan Z, Yildirim A, Chen PJ, Winograd P, Tran B, Lee YT, Li PS, Noor Z, Yokomizo M, Ahuja P, Zhu Y, Tseng HR, Tomlinson JS, Garon E, French S, Magyar CE, Dry S, Lajonchere C, Geschwind D, Choi G, Saab S, Alber F, Wong WH, Dubinett SM, Aberle DR, Agopian V, Han SB, Ni X, Li W, Zhou XJ. PMID: 36175411; PMCID: PMC9522828.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    22. Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Semin Oncol. 2022 Jul 02. Shin DS, Park K, Garon E, Dubinett S. PMID: 35851153.
      View in: PubMed   Mentions: 4     Fields:    
    23. cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution. Clin Cancer Res. 2022 05 02; 28(9):1841-1853. Li S, Zeng W, Ni X, Zhou Y, Stackpole ML, Noor ZS, Yuan Z, Neal A, Memarzadeh S, Garon EB, Dubinett SM, Li W, Zhou XJ. PMID: 35149536; PMCID: PMC9126584.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature. Commun Biol. 2022 05 02; 5(1):407. Basu A, Paul MK, Alioscha-Perez M, Grosberg A, Sahli H, Dubinett SM, Weiss S. PMID: 35501466; PMCID: PMC9061773.
      View in: PubMed   Mentions: 6  Translation:HumansCells
    25. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. J Immunother Cancer. 2022 05; 10(5). Govindan R, Aggarwal C, Antonia SJ, Davies M, Dubinett SM, Ferris A, Forde PM, Garon EB, Goldberg SB, Hassan R, Hellmann MD, Hirsch FR, Johnson ML, Malik S, Morgensztern D, Neal JW, Patel JD, Rimm DL, Sagorsky S, Schwartz LH, Sepesi B, Herbst RS. PMID: 35640927; PMCID: PMC9157337.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    26. Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100411. Liu S, Knochelmann HM, Lomeli SH, Hong A, Richardson M, Yang Z, Lim RJ, Wang Y, Dumitras C, Krysan K, Timmers C, Romeo MJ, Krieg C, O'Quinn EC, Horton JD, Dubinett SM, Paulos CM, Neskey DM, Lo RS. PMID: 34755131; PMCID: PMC8561238.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    27. Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC. JTO Clin Res Rep. 2021 Nov; 2(11):100242. Shahrouki P, Lee JM, Barclay J, Khan SN, Genshaft S, Abtin F, Dubinett SM, Lisberg A, Sharma S, Garon EB, Suh R. PMID: 34806054; PMCID: PMC8581369.
      View in: PubMed   Mentions:
    28. Early Diagnosis and Screening for Lung Cancer. Cold Spring Harb Perspect Med. 2021 09 01; 11(9). Kadara H, Tran LM, Liu B, Vachani A, Li S, Sinjab A, Zhou XJ, Dubinett SM, Krysan K. PMID: 34001525; PMCID: PMC8415293.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    29. COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California. JAMA Netw Open. 2021 09 01; 4(9):e2127582. Carson SL, Casillas A, Castellon-Lopez Y, Mansfield LN, Morris D, Barron J, Ntekume E, Landovitz R, Vassar SD, Norris KC, Dubinett SM, Garrison NA, Brown AF. PMID: 34591103; PMCID: PMC8485164.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    30. Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer. Cancers (Basel). 2021 Jul 18; 13(14). Saggese P, Martinez CA, Tran LM, Lim R, Dumitras C, Grogan T, Elashoff D, Ramin SR, Dubinett SM, Liu B, Scafoglio C. PMID: 34298808; PMCID: PMC8307650.
      View in: PubMed   Mentions: 1  
    31. Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis. Nat Commun. 2021 07 07; 12(1):4172. Li S, Noor ZS, Zeng W, Stackpole ML, Ni X, Zhou Y, Yuan Z, Wong WH, Agopian VG, Dubinett SM, Alber F, Li W, Garon EB, Zhou XJ. PMID: 34234141; PMCID: PMC8263778.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    32. Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss. Proc Natl Acad Sci U S A. 2021 05 11; 118(19). William WN, Zhao X, Bianchi JJ, Lin HY, Cheng P, Lee JJ, Carter H, Alexandrov LB, Abraham JP, Spetzler DB, Dubinett SM, Cleveland DW, Cavenee W, Davoli T, Lippman SM. PMID: 33952700; PMCID: PMC8126856.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    33. Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing. Cancer Discov. 2021 10; 11(10):2506-2523. Sinjab A, Han G, Treekitkarnmongkol W, Hara K, Brennan PM, Dang M, Hao D, Wang R, Dai E, Dejima H, Zhang J, Bogatenkova E, Sanchez-Espiridion B, Chang K, Little DR, Bazzi S, Tran LM, Krysan K, Behrens C, Duose DY, Parra ER, Raso MG, Solis LM, Fukuoka J, Zhang J, Sepesi B, Cascone T, Byers LA, Gibbons DL, Chen J, Moghaddam SJ, Ostrin EJ, Rosen D, Heymach JV, Scheet P, Dubinett SM, Fujimoto J, Wistuba II, Stevenson CS, Spira A, Wang L, Kadara H. PMID: 33972311; PMCID: PMC8487926.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    34. Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer. Cancer Res. 2021 06 15; 81(12):3295-3308. Li R, Salehi-Rad R, Crosson W, Momcilovic M, Lim RJ, Ong SL, Huang ZL, Zhang T, Abascal J, Dumitras C, Jing Z, Park SJ, Krysan K, Shackelford DB, Tran LM, Liu B, Dubinett SM. PMID: 33853830; PMCID: PMC8776246.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    35. Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic. J Clin Transl Sci. 2021 Mar 16; 5(1):e107. Ford DE, Johnson A, Nichols JJ, Rothwell E, Dubinett S, Naeim A. PMID: 34192061; PMCID: PMC8220014.
      View in: PubMed   Mentions: 5  
    36. Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients. Cancers (Basel). 2021 Mar 12; 13(6). Han G, Sinjab A, Hara K, Treekitkarnmongkol W, Brennan P, Chang K, Bogatenkova E, Sanchez-Espiridion B, Behrens C, Solis LM, Gao B, Girard L, Zhang J, Sepesi B, Cascone T, Byers LA, Gibbons DL, Chen J, Moghaddam SJ, Ostrin EJ, Scheet P, Fujimoto J, Shay J, Heymach JV, Minna JD, Dubinett S, Wistuba II, Stevenson CS, Spira AE, Wang L, Kadara H. PMID: 33809063; PMCID: PMC7998226.
      View in: PubMed   Mentions: 4  
    37. Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC. JTO Clin Res Rep. 2021 Apr; 2(4):100150. Young PA, Márquez-Garbán DC, Noor ZS, Moatamed N, Elashoff D, Grogan T, Romero T, Sasano H, Saito R, Rausch R, Hamilton N, Dubinett SM, Garon EB, Pietras RJ. PMID: 34590007; PMCID: PMC8474426.
      View in: PubMed   Mentions: 3  
    38. Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden. Cancer Immunol Immunother. 2021 Aug; 70(8):2389-2400. Salehi-Rad R, Li R, Tran LM, Lim RJ, Abascal J, Momcilovic M, Park SJ, Ong SL, Shabihkhani M, Huang ZL, Paul M, Shackelford DB, Krysan K, Liu B, Dubinett SM. PMID: 33507343; PMCID: PMC8289771.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    39. Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity. Cancer Discov. 2021 03; 11(3):714-735. Hong A, Piva M, Liu S, Hugo W, Lomeli SH, Zoete V, Randolph CE, Yang Z, Wang Y, Lee JJ, Lo SJ, Sun L, Vega-Crespo A, Garcia AJ, Shackelford DB, Dubinett SM, Scumpia PO, Byrum SD, Tackett AJ, Donahue TR, Michielin O, Holmen SL, Ribas A, Moriceau G, Lo RS. PMID: 33318037; PMCID: PMC7933113.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    40. Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44. Nat Cancer. 2020 12; 1(12):1167-1175. Cummings AL, Gukasyan J, Lu HY, Grogan T, Sunga G, Fares CM, Hornstein N, Zaretsky J, Carroll J, Bachrach B, Akingbemi WO, Li D, Noor Z, Lisberg A, Goldman JW, Elashoff D, Bui AAT, Ribas A, Dubinett SM, Rossetti M, Garon EB. PMID: 35121931.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    41. Immunosurveillance and Regression in the Context of Squamous Pulmonary Premalignancy. Cancer Discov. 2020 10; 10(10):1442-1444. Krysan K, Tran LM, Dubinett SM. PMID: 33004476; PMCID: PMC8396076.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    42. Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa424. Schwab K, Hamidi S, Chung A, Lim RJ, Khanlou N, Hoesterey D, Dumitras C, Adeyiga OB, Phan-Tang M, Wang TS, Saggar R, Goldstein J, Belperio JA, Dubinett SM, Kim JT, Salehi-Rad R. PMID: 33204749; PMCID: PMC7543619.
      View in: PubMed   Mentions: 3  
    43. Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells. Cell Stem Cell. 2020 10 01; 27(4):663-678.e8. Dost AFM, Moye AL, Vedaie M, Tran LM, Fung E, Heinze D, Villacorta-Martin C, Huang J, Hekman R, Kwan JH, Blum BC, Louie SM, Rowbotham SP, Sainz de Aja J, Piper ME, Bhetariya PJ, Bronson RT, Emili A, Mostoslavsky G, Fishbein GA, Wallace WD, Krysan K, Dubinett SM, Yanagawa J, Kotton DN, Kim CF. PMID: 32891189; PMCID: PMC7541765.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    44. Lung Cancer and Immunity Markers. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2423-2430. Lim RJ, Liu B, Krysan K, Dubinett SM. PMID: 32856614; PMCID: PMC8294063.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis. J Gen Intern Med. 2020 12; 35(12):3581-3590. Buhr RG, Jackson NJ, Kominski GF, Dubinett SM, Mangione CM, Ong MK. PMID: 32556878; PMCID: PMC7728926.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    46. Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci Rep. 2020 Mar 04; 10(1):4386. Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ, Huang ZL, Walser TC, Heinrich EL, Lee G, Salehi-Rad R, Crosson WP, Pagano PC, Paul MK, Xu S, Herschman H, Krysan K, Dubinett S. PMID: 32127587; PMCID: PMC7054550.
      View in: PubMed   Mentions: 2     Fields:    
    47. The Biology of Lung Cancer: Development of More Effective Methods for Prevention, Diagnosis, and Treatment. Clin Chest Med. 2020 03; 41(1):25-38. Salehi-Rad R, Li R, Paul MK, Dubinett SM, Liu B. PMID: 32008627.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    48. FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells. Am J Transl Res. 2020; 12(2):409-427. Lee MH, Yanagawa J, Tran L, Walser TC, Bisht B, Fung E, Park SJ, Zeng G, Krysan K, Wallace WD, Paul MK, Girard L, Gao B, Minna JD, Dubinett SM, Lee JM. PMID: 32194893; PMCID: PMC7061839.
      View in: PubMed   Mentions: 11  
    49. Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease. J Hosp Med. 2020 04 01; 15(4):219-227. Buhr RG, Jackson NJ, Dubinett SM, Kominski GF, Mangione CM, Ong MK. PMID: 32118572; PMCID: PMC7153488.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. The Role of Interleukin 1β in the Pathogenesis of Lung Cancer. JTO Clin Res Rep. 2020 Mar; 1(1):100001. Garon EB, Chih-Hsin Yang J, Dubinett SM. PMID: 34589908; PMCID: PMC8474414.
      View in: PubMed   Mentions: 24  
    51. Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci Rep. 2020 01 15; 10(1):377. Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ, Huang ZL, Walser TC, Heinrich EL, Lee G, Salehi-Rad R, Crosson WP, Pagano PC, Paul MK, Xu S, Herschman H, Krysan K, Dubinett S. PMID: 31941995; PMCID: PMC6962381.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    52. Publisher Correction: In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer. Nature. 2020 01; 577(7791):E7. Momcilovic M, Jones A, Bailey ST, Waldmann CM, Li R, Lee JT, Abdelhady G, Gomez A, Holloway T, Schmid E, Stout D, Fishbein MC, Stiles L, Dabir DV, Dubinett SM, Christofk H, Shirihai O, Koehler CM, Sadeghi S, Shackelford DB. PMID: 31896820.
      View in: PubMed   Mentions:    Fields:    
    53. CCL21 Programs Immune Activity in Tumor Microenvironment. Adv Exp Med Biol. 2020; 1231:67-78. Sharma S, Kadam P, Dubinett S. PMID: 32060847.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    54. Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer. Transl Lung Cancer Res. 2019 Dec; 8(Suppl 4):S331-S333. Li R, Dubinett SM. PMID: 32038908; PMCID: PMC6987369.
      View in: PubMed   Mentions: 2  
    55. In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer. Nature. 2019 11; 575(7782):380-384. Momcilovic M, Jones A, Bailey ST, Waldmann CM, Li R, Lee JT, Abdelhady G, Gomez A, Holloway T, Schmid E, Stout D, Fishbein MC, Stiles L, Dabir DV, Dubinett SM, Christofk H, Shirihai O, Koehler CM, Sadeghi S, Shackelford DB. PMID: 31666695; PMCID: PMC7328016.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    56. Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices. BMC Health Serv Res. 2019 Oct 15; 19(1):701. Buhr RG, Jackson NJ, Kominski GF, Dubinett SM, Ong MK, Mangione CM. PMID: 31615508; PMCID: PMC6794890.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    57. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer. Am J Respir Crit Care Med. 2019 09 15; 200(6):742-750. Kadara H, Sivakumar S, Jakubek Y, San Lucas FA, Lang W, McDowell T, Weber Z, Behrens C, Davies GE, Kalhor N, Moran C, El-Zein R, Mehran R, Swisher SG, Wang J, Zhang J, Fujimoto J, Fowler J, Heymach JV, Dubinett S, Spira AE, Ehli EA, Wistuba II, Scheet P. PMID: 30896962; PMCID: PMC6775870.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    58. Gene Expression Alterations in the Bronchial Epithelium of e-Cigarette Users. Chest. 2019 10; 156(4):764-773. Corbett SE, Nitzberg M, Moses E, Kleerup E, Wang T, Perdomo C, Perdomo C, Liu G, Xiao X, Liu H, Elashoff DA, Brooks DR, O'Connor GT, Dubinett SM, Spira A, Lenburg ME. PMID: 31233743; PMCID: PMC6859252.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    59. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy. Cancer Res. 2019 Oct 01; 79(19):5022-5033. Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle DR, Spira AE, Elashoff DA, Wallace WD, Fishbein MC, Dubinett SM. PMID: 31142513; PMCID: PMC6774823.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    60. Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer. Clin Cancer Res. 2019 08 15; 25(16):5061-5068. Hu-Lieskovan S, Lisberg A, Zaretsky JM, Grogan TR, Rizvi H, Wells DK, Carroll J, Cummings A, Madrigal J, Jones B, Gukasyan J, Shintaku IP, Slamon D, Dubinett S, Goldman JW, Elashoff D, Hellmann MD, Ribas A, Garon EB. PMID: 31113840; PMCID: PMC6901027.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    61. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions. Nat Commun. 2019 04 23; 10(1):1856. Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, Perdomo C, Schaffer M, Liu G, Zhang S, Liu H, Vick J, Dhillon SS, Platero SJ, Dubinett SM, Stevenson C, Reid ME, Lenburg ME, Spira AE. PMID: 31015447; PMCID: PMC6478943.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsPHPublic Health
    62. Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema. J Thorac Dis. 2019 Feb; 11(2):382-385. Salehi-Rad R, Dubinett SM. PMID: 30962980; PMCID: PMC6409254.
      View in: PubMed   Mentions: 1  
    63. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med. 2018 11 14; 10(467). Scafoglio CR, Villegas B, Abdelhady G, Bailey ST, Liu J, Shirali AS, Wallace WD, Magyar CE, Grogan TR, Elashoff D, Walser T, Yanagawa J, Aberle DR, Barrio JR, Dubinett SM, Shackelford DB. PMID: 30429355; PMCID: PMC6428683.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimals
    64. Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018 10 01; 198(7):835-837. Salehi-Rad R, Dubinett SM. PMID: 29589957.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    65. Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assay. Proc Natl Acad Sci U S A. 2018 10 02; 115(40):9986-9991. Dhar M, Lam JN, Walser T, Dubinett SM, Rettig MB, Di Carlo D. PMID: 30224472; PMCID: PMC6176626.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    66. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J Immunother Cancer. 2018 07 17; 6(1):75. Brahmer JR, Govindan R, Anders RA, Antonia SJ, Sagorsky S, Davies MJ, Dubinett SM, Ferris A, Gandhi L, Garon EB, Hellmann MD, Hirsch FR, Malik S, Neal JW, Papadimitrakopoulou VA, Rimm DL, Schwartz LH, Sepesi B, Yeap BY, Rizvi NA, Herbst RS. PMID: 30012210; PMCID: PMC6048854.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    67. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98. Garon EB, Siegfried JM, Stabile LP, Young PA, Marquez-Garban DC, Park DJ, Patel R, Hu EH, Sadeghi S, Parikh RJ, Reckamp KL, Adams B, Elashoff RM, Elashoff D, Grogan T, Wang HJ, Dacic S, Brennan M, Valdes Y, Davenport S, Dubinett SM, Press MF, Slamon DJ, Pietras RJ. PMID: 30089602; PMCID: PMC6118115.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    68. Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer. Sci Rep. 2018 06 13; 8(1):9032. Chattopadhyay A, Yang X, Mukherjee P, Sulaiman D, Fogelman HR, Grijalva V, Dubinett S, Wasler TC, Paul MK, Salehi-Rad R, Mack JJ, Iruela-Arispe ML, Navab M, Fogelman AM, Reddy ST. PMID: 29899427; PMCID: PMC5998131.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    69. The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma. Cancer Cell. 2018 05 14; 33(5):905-921.e5. Momcilovic M, Bailey ST, Lee JT, Fishbein MC, Braas D, Go J, Graeber TG, Parlati F, Demo S, Li R, Walser TC, Gricowski M, Shuman R, Ibarra J, Fridman D, Phelps ME, Badran K, St John M, Bernthal NM, Federman N, Yanagawa J, Dubinett SM, Sadeghi S, Christofk HR, Shackelford DB. PMID: 29763624; PMCID: PMC6451645.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    70. Summarizing performance for genome scale measurement of miRNA: reference samples and metrics. BMC Genomics. 2018 03 06; 19(1):180. Pine PS, Lund SP, Parsons JR, Vang LK, Mahabal AA, Cinquini L, Kelly SC, Kincaid H, Crichton DJ, Spira A, Liu G, Gower AC, Pass HI, Goparaju C, Dubinett SM, Krysan K, Stass SA, Kukuruga D, Van Keuren-Jensen K, Courtright-Lim A, Thompson KL, Rosenzweig BA, Sorbara L, Srivastava S, Salit ML. PMID: 29510677; PMCID: PMC5838960.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res. 2018 04 15; 78(8):1986-1999. Walser TC, Jing Z, Tran LM, Lin YQ, Yakobian N, Wang G, Krysan K, Zhu LX, Sharma S, Lee MH, Belperio JA, Ooi AT, Gomperts BN, Shay JW, Larsen JE, Minna JD, Hong LS, Fishbein MC, Dubinett SM. PMID: 29431637; PMCID: PMC5899686.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    72. Impact of Chronic Obstructive Pulmonary Disease on Immune-based Treatment for Lung Cancer. Moving toward Disease Interception. Am J Respir Crit Care Med. 2018 02 01; 197(3):278-280. Dubinett SM, Spira AE. PMID: 29072842.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma. Cancer Res. 2017 11 15; 77(22):6119-6130. Sivakumar S, Lucas FAS, McDowell TL, Lang W, Xu L, Fujimoto J, Zhang J, Futreal PA, Fukuoka J, Yatabe Y, Dubinett SM, Spira AE, Fowler J, Hawk ET, Wistuba II, Scheet P, Kadara H. PMID: 28951454; PMCID: PMC5774855.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    74. Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients. Cancer Invest. 2017 Oct 21; 35(9):573-585. Hocker JR, Deb SJ, Li M, Lerner MR, Lightfoot SA, Quillet AA, Hanas RJ, Reinersman M, Thompson JL, Vu NT, Kupiec TC, Brackett DJ, Peyton MD, Dubinett SM, Burkhart HM, Postier RG, Hanas JS. PMID: 28949774.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    75. Use of a Novel Polymer in an Animal Model of Head and Neck Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2018 01; 158(1):110-117. Pellionisz PA, Lin Y, Mallen-St Clair J, Luo J, Suwarnasarn A, Schaue D, Elashoff DA, Palma-Diaz F, Dubinett SM, Sharma S, Wu B, St John MA. PMID: 28895464.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    76. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection. Cancer Prev Res (Phila). 2017 Nov; 10(11):651-659. Pavel AB, Campbell JD, Liu G, Elashoff D, Dubinett S, Smith K, Whitney D, Lenburg ME, Spira A, AEGIS Study Team. PMID: 28877936; PMCID: PMC6758560.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    77. Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties. Cancer Prev Res (Phila). 2017 Sep; 10(9):514-524. Pagano PC, Tran LM, Bendris N, O'Byrne S, Tse HT, Sharma S, Hoech JW, Park SJ, Liclican EL, Jing Z, Li R, Krysan K, Paul MK, Fontebasso Y, Larsen JE, Hakimi S, Seki A, Fishbein MC, Gimzewski JK, Carlo DD, Minna JD, Walser TC, Dubinett SM. PMID: 28754664; PMCID: PMC5584580.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    78. Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration. Clin Cancer Res. 2017 Aug 15; 23(16):4556-4568. Lee JM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, Tumeh PC, Abtin F, Suh R, Reckamp KL, Lee G, Wallace WD, Lee S, Zeng G, Elashoff DA, Sharma S, Dubinett SM. PMID: 28468947; PMCID: PMC5599263.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCellsCTClinical Trials
    79. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017 03 24; 18(1):53. Kang S, Li Q, Chen Q, Zhou Y, Park S, Lee G, Grimes B, Krysan K, Yu M, Wang W, Alber F, Sun F, Dubinett SM, Li W, Zhou XJ. PMID: 28335812; PMCID: PMC5364586.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    80. Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer. Cell Rep. 2017 01 17; 18(3):601-610. Momcilovic M, Bailey ST, Lee JT, Fishbein MC, Magyar C, Braas D, Graeber T, Jackson NJ, Czernin J, Emberley E, Gross M, Janes J, Mackinnon A, Pan A, Rodriguez M, Works M, Zhang W, Parlati F, Demo S, Garon E, Krysan K, Walser TC, Dubinett SM, Sadeghi S, Christofk HR, Shackelford DB. PMID: 28099841; PMCID: PMC5260616.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    81. Assessing Researcher Needs for a Virtual Biobank. Biopreserv Biobank. 2017 Jun; 15(3):203-210. van Draanen J, Davidson P, Bour-Jordan H, Bowman-Carpio L, Boyle D, Dubinett S, Gardner B, Gardner J, McFall C, Mercola D, Nakazono T, Soares S, Stoppler H, Tempero M, Vandenberg S, Wan YJ, Dry S. PMID: 27929677; PMCID: PMC5749588.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    82. Lung Cancer: Evolving Concepts in Management. Semin Respir Crit Care Med. 2016 10; 37(5):647-648. Arenberg D, Dubinett SM. PMID: 27732986.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Molecular Impact of Electronic Cigarette Aerosol Exposure in Human Bronchial Epithelium. Toxicol Sci. 2017 01; 155(1):248-257. Moses E, Wang T, Corbett S, Jackson GR, Drizik E, Perdomo C, Perdomo C, Kleerup E, Brooks D, O'Connor G, Dubinett S, Hayden P, Lenburg ME, Spira A. PMID: 27701119; PMCID: PMC5216655.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    84. p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma. Oral Oncol. 2016 09; 60:81-9. Lin Y, Mallen-St Clair J, Wang G, Luo J, Palma-Diaz F, Lai C, Elashoff DA, Sharma S, Dubinett SM, St John M. PMID: 27531877.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    85. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4. Cell Rep. 2016 Feb 23; 14(7):1590-1601. Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PAL, Gardner BK, Behbahan IS, Horvath S, Chia D, Mellinghoff IK, Hurvitz SA, Dubinett SM, Critchlow SE, Kurdistani SK, Goodglick L, Braas D, Graeber TG, Christofk HR. PMID: 26876179; PMCID: PMC4816454.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansAnimalsCells
    86. Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers. Cancer Res. 2015 Nov 15; 75(22):4910-22. Momcilovic M, McMickle R, Abt E, Seki A, Simko SA, Magyar C, Stout DB, Fishbein MC, Walser TC, Dubinett SM, Shackelford DB. PMID: 26574479; PMCID: PMC4654699.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    87. p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol. 2015 Oct; 51(10):921-8. Lin Y, Mallen-St Clair J, Luo J, Sharma S, Dubinett S, St John M. PMID: 26306422.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    88. Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer. Cancer. 2015 Sep 15; 121(18):3298-306. Reckamp KL, Koczywas M, Cristea MC, Dowell JE, Wang HJ, Gardner BK, Milne GL, Figlin RA, Fishbein MC, Elashoff RM, Dubinett SM. PMID: 26033830; PMCID: PMC4864011.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    89. GITR agonist enhances vaccination responses in lung cancer. Oncoimmunology. 2015 Apr; 4(4):e992237. Zhu LX, Davoodi M, Srivastava MK, Kachroo P, Lee JM, St John M, Harris-White M, Huang M, Strieter RM, Dubinett S, Sharma S. PMID: 26137407; PMCID: PMC4485739.
      View in: PubMed   Mentions: 9     Fields:    
    90. Drug Development for Metastasis Prevention. Crit Rev Oncog. 2015; 20(5-6):449-73. Fontebasso Y, Dubinett SM. PMID: 27279241; PMCID: PMC6497172.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    91. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway. J Cancer Sci Ther. 2014 Nov; 6(11):468-477. Lee MH, Kachroo P, Pagano PC, Yanagawa J, Wang G, Walser TC, Krysan K, Sharma S, John MS, Dubinett SM, Lee JM. PMID: 26523208; PMCID: PMC4624255.
      View in: PubMed   Mentions: 7  
    92. Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy. Cancer Prev Res (Phila). 2014 Aug; 7(8):845-55. Liclican EL, Walser TC, Hazra S, Krysan K, Park SJ, Pagano PC, Gardner BK, Larsen JE, Minna JD, Dubinett SM. PMID: 24913817; PMCID: PMC4125465.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    93. A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model. Otolaryngol Head Neck Surg. 2014 Sep; 151(3):447-53. Lin Y, Luo J, Zhu WE, Srivastava M, Schaue D, Elashoff DA, Dubinett SM, Sharma S, Wu B, St John MA. PMID: 24825873; PMCID: PMC4167678.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    94. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis. Cancer Prev Res (Phila). 2014 May; 7(5):487-95. Ooi AT, Gower AC, Zhang KX, Vick JL, Hong L, Nagao B, Wallace WD, Elashoff DA, Walser TC, Dubinett SM, Pellegrini M, Lenburg ME, Spira A, Gomperts BN. PMID: 24618292; PMCID: PMC4059064.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    95. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43. Hanas JS, Peyton MD, Lerner MR, Lightfoot SA, Deb SJ, Hanas RJ, Vu NT, Kupiec TC, Stowell DE, Brackett DJ, Dubinett SM, Hocker JR. PMID: 24579933.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    96. PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC. Mol Cancer Res. 2014 May; 12(5):765-74. Krysan K, Kusko R, Grogan T, O'Hearn J, Reckamp KL, Walser TC, Garon EB, Lenburg ME, Sharma S, Spira AE, Elashoff D, Dubinett SM. PMID: 24469837; PMCID: PMC4020971.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    97. Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer. J Cancer Res Clin Oncol. 2014 Mar; 140(3):443-52. Garon EB, Christofk HR, Hosmer W, Britten CD, Bahng A, Crabtree MJ, Hong CS, Kamranpour N, Pitts S, Kabbinavar F, Patel C, von Euw E, Black A, Michelakis ED, Dubinett SM, Slamon DJ. PMID: 24442098; PMCID: PMC3939783.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCellsCTClinical Trials
    98. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res. 2013 Nov 25; 32:97. Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM. PMID: 24274066; PMCID: PMC3906956.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    99. A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis. Cancer Prev Res (Phila). 2014 Jan; 7(1):150-60. Grant JL, Fishbein MC, Hong LS, Krysan K, Minna JD, Shay JW, Walser TC, Dubinett SM. PMID: 24253315; PMCID: PMC3919444.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    100. MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):18946-51. Perdomo C, Campbell JD, Gerrein J, Tellez CS, Garrison CB, Walser TC, Drizik E, Si H, Gower AC, Vick J, Anderlind C, Jackson GR, Mankus C, Schembri F, O'Hara C, Gomperts BN, Dubinett SM, Hayden P, Belinsky SA, Lenburg ME, Spira A. PMID: 24158479; PMCID: PMC3839685.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    101. Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium. Clin Transl Sci. 2013 Dec; 6(6):435-43. Ofili EO, Fair A, Norris K, Verbalis JG, Poland R, Bernard G, Stephens DS, Dubinett SM, Imperato-McGinley J, Dottin RP, Pulley J, West A, Brown A, Mellman TA. PMID: 24119157; PMCID: PMC4038384.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    102. Challenge and opportunity of targeted lung cancer chemoprevention. J Clin Oncol. 2013 Nov 20; 31(33):4169-71. Dubinett SM, Spira A. PMID: 24002497.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    103. Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. Am J Transl Res. 2013; 5(5):481-96. Krysan K, Cui X, Gardner BK, Reckamp KL, Wang X, Hong L, Walser TC, Rodriguez NL, Pagano PC, Garon EB, Brothers JF, Elashoff D, Lee JM, Spira AE, Sharma S, Fishbein MC, Dubinett SM. PMID: 23977408; PMCID: PMC3745436.
      View in: PubMed   Mentions: 13  
    104. Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer. Am J Cancer Res. 2013; 3(4):374-89. Liao W, Jordaan G, Srivastava MK, Dubinett S, Sharma S, Sharma S. PMID: 23977447; PMCID: PMC3744017.
      View in: PubMed   Mentions: 15  
    105. Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res. 2013 May 01; 19(9):2584-91. Ohashi K, Sequist LV, Arcila ME, Lovly CM, Chen X, Rudin CM, Moran T, Camidge DR, Vnencak-Jones CL, Berry L, Pan Y, Sasaki H, Engelman JA, Garon EB, Dubinett SM, Franklin WA, Riely GJ, Sos ML, Kris MG, Dias-Santagata D, Ladanyi M, Bunn PA, Pao W. PMID: 23515407; PMCID: PMC3643999.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    106. TLR3 agonists and proinflammatory antitumor activities. Expert Opin Ther Targets. 2013 May; 17(5):481-3. Sharma S, Zhu L, Davoodi M, Harris-White M, Lee JM, St John M, Salgia R, Dubinett S. PMID: 23506058; PMCID: PMC3758767.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    107. The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. Mol Cancer Ther. 2013 Jun; 12(6):890-900. Garon EB, Finn RS, Hamidi H, Dering J, Pitts S, Kamranpour N, Desai AJ, Hosmer W, Ide S, Avsar E, Jensen MR, Quadt C, Liu M, Dubinett SM, Slamon DJ. PMID: 23493311; PMCID: PMC3681857.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    108. Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):270-8. Garon EB, Pietras RJ, Finn RS, Kamranpour N, Pitts S, Márquez-Garbán DC, Desai AJ, Dering J, Hosmer W, von Euw EM, Dubinett SM, Slamon DJ. PMID: 23399957; PMCID: PMC3573351.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    109. CCL21 Chemokine Therapy for Lung Cancer. Int Trends Immun. 2013 Jan; 1(1):10-15. Sharma S, Zhu L, Srivastava MK, Harris-White M, Huang M, Lee JM, Rosen F, Lee G, Wang G, Kickhoefer V, Rome LH, Baratelli F, St John M, Reckamp K, Chul-Yang S, Hillinger S, Strieter R, Dubinett S. PMID: 25264541; PMCID: PMC4175527.
      View in: PubMed   Mentions: 9  
    110. Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancer. Cancer Prev Res (Phila). 2013 Jan; 6(1):4-7. Gomperts BN, Walser TC, Spira A, Dubinett SM. PMID: 23233734; PMCID: PMC3717378.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    111. Targeting MDSCs enhance therapeutic vaccination responses against lung cancer. Oncoimmunology. 2012 Dec 01; 1(9):1650-1651. Srivastava MK, Dubinett S, Sharma S. PMID: 23264925; PMCID: PMC3525634.
      View in: PubMed   Mentions: 14     Fields:    
    112. CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer. Am J Respir Crit Care Med. 2012 Nov 15; 186(10):940-1. Sharma S, Dubinett S, Salgia R. PMID: 23155211; PMCID: PMC4249776.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    113. Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1. Biochem Biophys Res Commun. 2012 Nov 02; 427(4):725-30. Lu QY, Jin Y, Mao JT, Zhang ZF, Heber D, Dubinett SM, Rao J. PMID: 23036202; PMCID: PMC3490045.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    114. Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer. Immunotargets Ther. 2012 Oct 01; 2012(1):7-12. Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S. PMID: 24791250; PMCID: PMC4004632.
      View in: PubMed   Mentions: 15  
    115. Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies. Br J Cancer. 2012 Aug 07; 107(4):707-12. St John MA, Wang G, Luo J, Dohadwala M, Hu D, Lin Y, Dennis M, Lee JM, Elashoff D, Lawhon T, Zaknoen SL, Burrows FJ, Dubinett SM. PMID: 22828609; PMCID: PMC3419945.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    116. Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One. 2012; 7(7):e40677. Srivastava MK, Zhu L, Harris-White M, Kar UK, Kar U, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S. PMID: 22815789; PMCID: PMC3398024.
      View in: PubMed   Mentions: 118     Fields:    Translation:AnimalsCellsPHPublic Health
    117. Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg. 2012 Oct; 147(4):726-32. Dennis M, Wang G, Luo J, Lin Y, Dohadwala M, Abemayor E, Elashoff DA, Sharma S, Dubinett SM, St John MA. PMID: 22568942; PMCID: PMC4167686.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    118. A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model. Arch Otolaryngol Head Neck Surg. 2012 Apr; 138(4):412-7. Hu D, Lau OD, Wang L, Wang G, Schaue D, Zhu L, Huang M, Lin Y, Dennis M, Abemayor E, Elashoff DA, Dubinett SM, McBride WH, Sharma S, Wu B, St John MA. PMID: 22508626; PMCID: PMC4167672.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    119. Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012 Apr; 5(2):121-9. CTSA Principal Investigators, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, Califf R, Stephens D, Mellman T, Verbalis J, Nadler L, Shekhar A, Ford D, Rizza R, Shaker R, Brady K, Murphy B, Cronstein B, Hochman J, Greenland P, Orwoll E, Sinoway L, Greenberg H, Jackson R, Coller B, Topol E, Guay-Woodford L, Runge M, Clark R, McClain D, Selker H, Lowery C, Dubinett S, Berglund L, Cooper D, Firestein G, Johnston SC, Solway J, Heubi J, Sokol R, Nelson D, Tobacman L, Rosenthal G, Aaronson L, Barohn R, Kern P, Sullivan J, Shanley T, Blazar B, Larson R, FitzGerald G, Reis S, Pearson T, Buchanan T, McPherson D, Brasier A, Toto R, Disis M, Drezner M, Bernard G, Clore J, Evanoff B, Imperato-McGinley J, Sherwin R, Pulley J. PMID: 22507116; PMCID: PMC3335735.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    120. Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy. 2012 Mar; 4(3):291-304. Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S. PMID: 22401635; PMCID: PMC3324285.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    121. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. Am J Physiol Lung Cell Mol Physiol. 2012 Jun 01; 302(11):L1150-8. Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK. PMID: 22345575; PMCID: PMC3379038.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    122. Mitotic inhibitors. J Thorac Oncol. 2011 Nov; 6(11 Suppl 4):S1791-2. Garon EB, Dubinett SM. PMID: 22005532; PMCID: PMC3812544.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    123. The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron. 2012 Apr; 5(1):5-18. Heinrich EL, Walser TC, Krysan K, Liclican EL, Grant JL, Rodriguez NL, Dubinett SM. PMID: 21922183; PMCID: PMC3343201.
      View in: PubMed   Mentions: 37  
    124. MUC1 peptide vaccine mediated antitumor activity in non-small cell lung cancer. Expert Opin Biol Ther. 2011 Aug; 11(8):987-90. Sharma S, Srivastava MK, Harris-White M, Lee JM, Dubinett S. PMID: 21711210; PMCID: PMC3132083.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    125. Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer. 2012 Jan; 75(1):38-44. Stoyanov E, Uddin M, Mankuta D, Dubinett SM, Levi-Schaffer F. PMID: 21733595.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    126. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila). 2011 Jul; 4(7):984-93. Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. PMID: 21733822; PMCID: PMC3153413.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    127. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 04; 365(5):395-409. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. PMID: 21714641; PMCID: PMC4356534.
      View in: PubMed   Mentions: 3741     Fields:    Translation:Humans
    128. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer. Clin Cancer Res. 2011 Jun 01; 17(11):3660-72. Andersson A, Srivastava MK, Harris-White M, Huang M, Zhu L, Elashoff D, Strieter RM, Dubinett SM, Sharma S. PMID: 21636553; PMCID: PMC3118413.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    129. Systematic quantitative characterization of cellular responses induced by multiple signals. BMC Syst Biol. 2011 May 30; 5:88. Al-Shyoukh I, Yu F, Feng J, Yan K, Dubinett S, Ho CM, Shamma JS, Sun R. PMID: 21624115; PMCID: PMC3138445.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    130. Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth. PLoS One. 2011 May 03; 6(5):e18758. Kar UK, Srivastava MK, Andersson A, Baratelli F, Huang M, Kickhoefer VA, Dubinett SM, Rome LH, Sharma S. PMID: 21559281; PMCID: PMC3086906.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    131. Evolving concepts in lung carcinogenesis. Semin Respir Crit Care Med. 2011 Feb; 32(1):32-43. Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, Minna JD, Dubinett SM. PMID: 21500122; PMCID: PMC3423907.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    132. Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients. Am J Transl Res. 2011 May 15; 3(3):226-33. Lee G, Gardner BK, Elashoff DA, Purcell CM, Sandha HS, Mao JT, Krysan K, Lee JM, Dubinett SM. PMID: 21654877; PMCID: PMC3102566.
      View in: PubMed   Mentions: 5  
    133. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma. Am J Otolaryngol. 2012 Jan-Feb; 33(1):6-13. Mendelsohn AH, Lai CK, Shintaku IP, Fishbein MC, Brugman K, Elashoff DA, Abemayor E, Dubinett SM, St John MA. PMID: 21439681; PMCID: PMC5875698.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    134. c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells. Clin Exp Metastasis. 2011 Apr; 28(4):391-404. Mortazavi F, Dubinett S, Rettig M. PMID: 21336985; PMCID: PMC3081060.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    135. Poly(ADP-ribose) polymerase inhibitors. J Thorac Oncol. 2010 Dec; 5(12 Suppl 6):S455-6. Garon EB, Dubinett SM. PMID: 21102236.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. Novel drugs--miscellaneous category. J Thorac Oncol. 2010 Dec; 5(12 Suppl 6):S468-9. Hosmer WD, Dubinett SM, Garon EB. PMID: 21102242.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. J Thorac Oncol. 2010 Oct; 5(10):1502-6. Patz EF, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, Gatsonis C, Duan F, Adams A, Apgar C, Medina RM, Aberle DR. PMID: 20871260; PMCID: PMC2963472.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    138. Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope. 2010 Sep; 120(9):1788-94. Mendelsohn AH, Lai CK, Shintaku IP, Elashoff DA, Dubinett SM, Abemayor E, St John MA. PMID: 20803740.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    139. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Res. 2010 Aug 15; 70(16):6639-48. Ooi AT, Mah V, Nickerson DW, Gilbert JL, Ha VL, Hegab AE, Horvath S, Alavi M, Maresh EL, Chia D, Gower AC, Lenburg ME, Spira A, Solis LM, Wistuba II, Walser TC, Wallace WD, Dubinett SM, Goodglick L, Gomperts BN. PMID: 20710044; PMCID: PMC2924777.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    140. Chemokines: can effector cells be redirected to the site of the tumor? Cancer J. 2010 Jul-Aug; 16(4):325-35. Dubinett SM, Lee JM, Sharma S, Mulé JJ. PMID: 20693843; PMCID: PMC3076643.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    141. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res. 2010 Jun 30; 2(4):356-67. Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. PMID: 20733946; PMCID: PMC2923860.
      View in: PubMed   Mentions: 31  
    142. p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells. Mol Cancer Res. 2010 May; 8(5):762-74. Mortazavi F, An J, Dubinett S, Rettig M. PMID: 20460685.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    143. The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC. Otolaryngol Head Neck Surg. 2010 May; 142(5):753-9. Dohadwala M, Wang G, Heinrich E, Luo J, Lau O, Shih H, Munaim Q, Lee G, Hong L, Lai C, Abemayor E, Fishbein MC, Elashoff DA, Dubinett SM, St John MA. PMID: 20416468.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    144. Cancer and inflammation: promise for biologic therapy. J Immunother. 2010 May; 33(4):335-51. Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT. PMID: 20386472; PMCID: PMC2941912.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansAnimals
    145. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection. Cancer Prev Res (Phila). 2010 Apr; 3(4):420-3. Gomperts BN, Spira A, Elashoff DE, Dubinett SM. PMID: 20332300.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res. 2009 Nov 15; 15(22):6820-9. Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, Sharma S, Dubinett SM. PMID: 19887480; PMCID: PMC2783274.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    147. Intracellular signaling molecules. J Thorac Oncol. 2009 Nov; 4(11 Suppl 3):S1057-8. Garon EB, Dubinett SM. PMID: 19861915.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    148. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res. 2009 Oct 01; 15(19):6018-27. St John MA, Dohadwala M, Luo J, Wang G, Lee G, Shih H, Heinrich E, Krysan K, Walser T, Hazra S, Zhu L, Lai C, Abemayor E, Fishbein M, Elashoff DA, Sharma S, Dubinett SM. PMID: 19789323; PMCID: PMC2782528.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    149. The launch of the american journal of translational research. Am J Transl Res. 2009 Sep 01; 1(1):i. Lee WH, Hung MC, Iczkowski KA, Languino LR, Dubinett SM, Wang D. PMID: 19966932; PMCID: PMC2776285.
      View in: PubMed   Mentions: 1  
    150. Towards effective immunotherapy for lung cancer: simultaneous targeting of tumor-initiating cells and immune pathways in the tumor microenvironment. Immunotherapy. 2009 Sep; 1(5):721-5. Dubinett S, Sharma S. PMID: 20636013.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    151. Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy. Chest. 2009 Sep; 136(3):924-926. Limsukon A, Susanto I, Soo Hoo GW, Dubinett SM, Batra RK. PMID: 19736197.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    152. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009 Jul; 15(4):303-7. Lee G, Walser TC, Dubinett SM. PMID: 19417670.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    153. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer. 2009 Jun 29; 9:213. Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM. PMID: 19563666; PMCID: PMC2708193.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    154. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. J Immunol. 2009 Jun 01; 182(11):6951-8. Andersson A, Yang SC, Huang M, Zhu L, Kar UK, Batra RK, Elashoff D, Strieter RM, Dubinett SM, Sharma S. PMID: 19454692.
      View in: PubMed   Mentions: 55     Fields:    Translation:AnimalsCells
    155. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst. 2009 Apr 15; 101(8):554-9. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. PMID: 19351920; PMCID: PMC2669099.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    156. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration. Proteomics. 2009 Feb; 9(3):757-67. Lu QY, Yang Y, Jin YS, Zhang ZF, Heber D, Li FP, Dubinett SM, Sondej MA, Loo JA, Rao JY. PMID: 19137550; PMCID: PMC2775082.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    157. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 2008 Dec 01; 5(8):811-5. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. PMID: 19017734; PMCID: PMC4080902.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    158. The partners--airflow obstruction, emphysema, and lung cancer. Am J Respir Crit Care Med. 2008 Oct 01; 178(7):665-6. Dubinett SM, Aberle DR, Tashkin DP, Mao JT. PMID: 18796652.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    159. Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase. Cancer Prev Res (Phila). 2008 Sep; 1(4):223-5. Dubinett SM, Mao JT, Hazra S. PMID: 19138963.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    160. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer. J Transl Med. 2008 Jul 22; 6:38. Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM. PMID: 18644162; PMCID: PMC2507704.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    161. Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer. J Thorac Oncol. 2008 May; 3(5):545-55. Einhorn LH, Bonomi P, Bunn PA, Camidge DR, Carbone DP, Choy H, Dubinett SM, Gandara DR, Gaspar LE, Govindan R, Johnson DH, Minna JD, Scagliotti G, West HJ, Herbst RS. PMID: 18449013; PMCID: PMC3374724.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    162. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol. 2008 Jun; 66(3):208-17. Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. PMID: 18304833; PMCID: PMC2483429.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    163. Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. J Thorac Oncol. 2008 Feb; 3(2):117-24. Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Mao J, Sharma S, Inge L, Rajasekaran A, Dubinett SM. PMID: 18303430.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    164. Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. J Thorac Oncol. 2008 Feb; 3(2):107-10. Krysan K, Lee JM, Dohadwala M, Gardner BK, Reckamp KL, Garon E, St John M, Sharma S, Dubinett SM. PMID: 18303428.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    165. Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. Eur J Nucl Med Mol Imaging. 2008 Jun; 35(6):1089-99. Su H, Seimbille Y, Ferl GZ, Bodenstein C, Fueger B, Kim KJ, Hsu YT, Dubinett SM, Phelps ME, Czernin J, Weber WA. PMID: 18239919.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    166. The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer. PPAR Res. 2008; 2008:790568. Hazra S, Peebles KA, Sharma S, Mao JT, Dubinett SM. PMID: 18769553; PMCID: PMC2526169.
      View in: PubMed   Mentions: 14  
    167. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther. 2007 Oct; 7(10):1405-21. Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. PMID: 17944566.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimals
    168. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells. Prostaglandins Leukot Essent Fatty Acids. 2007 Jul; 77(1):51-8. Hazra S, Dubinett SM. PMID: 17697767; PMCID: PMC2045645.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    169. EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2007 Nov; 37(5):578-88. Liu M, Yang SC, Sharma S, Luo J, Cui X, Peebles KA, Huang M, Sato M, Ramirez RD, Shay JW, Minna JD, Dubinett SM. PMID: 17600311; PMCID: PMC2048680.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    170. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase. Mol Pharmacol. 2007 Jun; 71(6):1715-20. Hazra S, Batra RK, Tai HH, Sharma S, Cui X, Dubinett SM. PMID: 17412838.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    171. Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC. Future Oncol. 2007 Apr; 3(2):149-53. Lee JM, Mao JT, Krysan K, Dubinett SM. PMID: 17381414.
      View in: PubMed   Mentions: 7     Fields:    
    172. Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling. Lab Invest. 2007 May; 87(5):456-65. Lu QY, Jin YS, Zhang ZF, Le AD, Heber D, Li FP, Dubinett SM, Rao JY. PMID: 17351649.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    173. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res. 2006 Oct; 21(10):1571-80. Feeley BT, Liu NQ, Conduah AH, Krenek L, Roth K, Dougall WC, Huard J, Dubinett S, Lieberman JR. PMID: 16995812.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    174. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res. 2006 Oct 01; 12(19):5659-67. Su H, Bodenstein C, Dumont RA, Seimbille Y, Dubinett S, Phelps ME, Herschman H, Czernin J, Weber W. PMID: 17020967.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    175. Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. J Immunol. 2006 Sep 15; 177(6):3582-9. Zeng G, Aldridge ME, Tian X, Seiler D, Zhang X, Jin Y, Rao J, Li W, Chen D, Langford MP, Duggan C, Belldegrun AS, Dubinett SM. PMID: 16951317.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    176. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK, AACR Task Force on Cancer Prevention. PMID: 16778094.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    177. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 1):3381-8. Reckamp KL, Krysan K, Morrow JD, Milne GL, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA. PMID: 16740761.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    178. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res. 2006 May 15; 66(10):5338-45. Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, Lin Y, Goodglick L, Krysan K, Fishbein MC, Hong L, Lai C, Cameron RB, Gemmill RM, Drabkin HA, Dubinett SM. PMID: 16707460.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    179. The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem. 2006 May; 6(3):209-20. Krysan K, Reckamp KL, Sharma S, Dubinett SM. PMID: 16712449.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    180. IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer. Biochem Biophys Res Commun. 2006 May 19; 343(4):995-1001. Cui X, Yang SC, Sharma S, Heuze-Vourc'h N, Dubinett SM. PMID: 16574063.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    181. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 2006 Mar 15; 66(6):3205-13. Yang SC, Batra RK, Hillinger S, Reckamp KL, Strieter RM, Dubinett SM, Sharma S. PMID: 16540672.
      View in: PubMed   Mentions: 40     Fields:    Translation:AnimalsCells
    182. Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance. Blood. 2006 Jun 01; 107(11):4484-90. Hoang B, Zhu L, Shi Y, Frost P, Yan H, Sharma S, Sharma S, Goodglick L, Dubinett S, Lichtenstein A. PMID: 16497971; PMCID: PMC1895799.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    183. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol. 2006 Feb 01; 176(3):1456-64. Pan J, Burdick MD, Belperio JA, Xue YY, Gerard C, Sharma S, Dubinett SM, Strieter RM. PMID: 16424173.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    184. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin Cancer Res. 2006 Jan 01; 12(1):314-20. Mao JT, Fishbein MC, Adams B, Roth MD, Goodglick L, Hong L, Burdick M, Strieter ER, Holmes C, Tashkin DP, Dubinett SM. PMID: 16397057.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    185. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005 Dec 15; 65(24):11287-91. Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ. PMID: 16357134.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimals
    186. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res. 2005 Nov 01; 11(21):7674-82. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S. PMID: 16278387.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    187. COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells. Microbes Infect. 2006 Feb; 8(2):478-86. Liu W, Dubinett S, Patterson SL, Kelly KA. PMID: 16297651.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    188. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med. 2005 Oct 03; 202(7):931-9. Rodriguez PC, Hernandez CP, Quiceno D, Dubinett SM, Zabaleta J, Ochoa JB, Gilbert J, Ochoa AC. PMID: 16186186; PMCID: PMC2213169.
      View in: PubMed   Mentions: 269     Fields:    Translation:AnimalsCells
    189. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol. 2005 Aug 01; 175(3):1483-90. Baratelli F, Lin Y, Zhu L, Yang SC, Heuzé-Vourc'h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM. PMID: 16034085.
      View in: PubMed   Mentions: 219     Fields:    Translation:HumansCells
    190. IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression. Biochem Biophys Res Commun. 2005 Jul 29; 333(2):470-5. Heuzé-Vourc'h N, Liu M, Dalwadi H, Baratelli FE, Zhu L, Goodglick L, Põld M, Sharma S, Ramirez RD, Shay JW, Minna JD, Strieter RM, Dubinett SM. PMID: 15950941.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    191. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res. 2005 Jul 15; 65(14):6275-81. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM. PMID: 16024629.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    192. Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses. J Immunol. 2005 Jul 15; 175(2):813-9. Sharma S, Zhu L, Yang SC, Zhang L, Lin J, Hillinger S, Gardner B, Reckamp K, Strieter RM, Huang M, Batra RK, Dubinett SM. PMID: 16002678.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    193. Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clin Lung Cancer. 2005 Jul; 7(1):30-9. Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM. PMID: 16098242.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    194. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 2005 Jun 15; 65(12):5211-20. Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Huang M, Batra RK, Dubinett SM. PMID: 15958566.
      View in: PubMed   Mentions: 192     Fields:    Translation:AnimalsCells
    195. PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells. J Leukoc Biol. 2005 Aug; 78(2):555-64. Baratelli F, Krysan K, Heuzé-Vourc'h N, Zhu L, Escuadro B, Sharma S, Reckamp K, Dohadwala M, Dubinett SM. PMID: 15908458.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    196. Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Int J Cancer. 2005 Mar 20; 114(2):268-73. Zeng G, Aldridge ME, Wang Y, Pantuck AJ, Wang AY, Liu YX, Han Y, Yuan YH, Robbins PF, Dubinett SM, deKernion JB, Belldegrun AS. PMID: 15540228.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    197. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Anticancer Res. 2005 Jan-Feb; 25(1A):107-15. Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR. PMID: 15816526.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    198. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann N Y Acad Sci. 2004 Dec; 1028:351-60. Strieter RM, Belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP. PMID: 15650260.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    199. Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix. J Immunol. 2004 Nov 01; 173(9):5458-66. Baratelli FE, Heuzé-Vourc'h N, Krysan K, Dohadwala M, Riedl K, Sharma S, Dubinett SM. PMID: 15494493.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    200. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin Cancer Res. 2004 Oct 15; 10(20):6872-8. Mao JT, Tsu IH, Dubinett SM, Adams B, Sarafian T, Baratelli F, Roth MD, Serio KJ. PMID: 15501964.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    201. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep 15; 64(18):6359-62. Krysan K, Dalwadi H, Sharma S, Põld M, Dubinett S. PMID: 15374938.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    202. Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer. Cancer Res. 2004 Sep 15; 64(18):6549-55. Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM. PMID: 15374967.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    203. Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture? J Clin Oncol. 2004 Aug 15; 22(16):3209-11. Dubinett SM, Elashoff D, Meyerson M. PMID: 15249586.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    204. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat. 2004 Jun; 7(3):169-84. Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM. PMID: 15296859.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    205. Interleukin-7 and transforming growth factor-beta play counter-regulatory roles in protein kinase C-delta-dependent control of fibroblast collagen synthesis in pulmonary fibrosis. J Biol Chem. 2004 Jul 02; 279(27):28315-9. Zhang L, Keane MP, Zhu LX, Sharma S, Rozengurt E, Strieter RM, Dubinett SM, Huang M. PMID: 15133032.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    206. Cyclooxygenase-2-dependent expression of survivin in non-small cell lung cancer. Chest. 2004 May; 125(5 Suppl):140S. Krysan K, Dohadwala M, Luo J, Lin Y, Zhu L, Heuze-Vourc'h N, Goodglick L, Merchant F, Seligson D, Pold M, Strieter R, Sharma S, Dubinett S. PMID: 15136466.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    207. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin Cancer Res. 2004 Apr 15; 10(8):2891-901. Yang SC, Hillinger S, Riedl K, Zhang L, Zhu L, Huang M, Atianzar K, Kuo BY, Gardner B, Batra RK, Strieter RM, Dubinett SM, Sharma S. PMID: 15102698.
      View in: PubMed   Mentions: 56     Fields:    Translation:AnimalsCells
    208. COX-2 inhibition and lung cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):45-52. Sandler AB, Dubinett SM. PMID: 15179623.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimals
    209. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Res. 2004 Mar 01; 64(5):1853-60. Põld M, Zhu LX, Sharma S, Burdick MD, Lin Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, Mao JT, Batra RK, Strieter RM, Dubinett SM. PMID: 14996749.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    210. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol. 2004 Feb; 147(1-2):95-8. Gardner B, Zhu LX, Roth MD, Tashkin DP, Dubinett SM, Sharma S. PMID: 14741436.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    211. EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model. J Immunol. 2003 Dec 15; 171(12):6457-65. Hillinger S, Yang SC, Zhu L, Huang M, Duckett R, Atianzar K, Batra RK, Strieter RM, Dubinett SM, Sharma S. PMID: 14662845.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    212. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5835-41. Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM. PMID: 14676104.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    213. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J. 2004 Jan; 18(1):206-8. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Põld M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S. PMID: 14597555.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    214. Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells. Mol Cancer. 2003 Nov 02; 2:35. Riedl K, Baratelli F, Batra RK, Yang SC, Luo J, Escuadro B, Figlin R, Strieter R, Sharma S, Dubinett S. PMID: 14613584; PMCID: PMC270078.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    215. Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Hum Gene Ther. 2003 Nov 01; 14(16):1511-24. Sharma S, Batra RK, Yang SC, Hillinger S, Zhu L, Atianzar K, Strieter RM, Riedl K, Huang M, Dubinett SM. PMID: 14577913; PMCID: PMC1471881.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    216. Methanandamide increases COX-2 expression and tumor growth in murine lung cancer. FASEB J. 2003 Nov; 17(14):2157-9. Gardner B, Zhu LX, Sharma S, Tashkin DP, Dubinett SM. PMID: 12958151.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    217. Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells. Cancer Res. 2003 Aug 15; 63(16):5065-72. Zhang L, Sharma S, Zhu LX, Kogai T, Hershman JM, Brent GA, Dubinett SM, Huang M. PMID: 12941836.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    218. SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10. Mol Cancer. 2003 Apr 15; 2:22. Sharma S, Yang SC, Hillinger S, Zhu LX, Huang M, Batra RK, Lin JF, Burdick MD, Strieter RM, Dubinett SM. PMID: 12740040; PMCID: PMC155639.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    219. IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol. 2003 Apr 01; 170(7):3585-91. Zhu LX, Sharma S, Gardner B, Escuadro B, Atianzar K, Tashkin DP, Dubinett SM. PMID: 12646621.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    220. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res. 2003 Mar; 9(3):961-8. Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, Huang M, Dohadwala M, Batra RK, Dubinett SM. PMID: 12631593.
      View in: PubMed   Mentions: 74     Fields:    Translation:AnimalsCells
    221. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. Cancer Res. 2003 Feb 15; 63(4):766-70. Heuze-Vourc'h N, Zhu L, Krysan K, Batra RK, Sharma S, Dubinett SM. PMID: 12591723.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    222. Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism. Cancer Res. 2003 Feb 01; 63(3):642-6. Batra RK, Lin Y, Sharma S, Dohadwala M, Luo J, Pold M, Dubinett SM. PMID: 12566308.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    223. Cyclooxygenase-2 in lung cancer. Prog Exp Tumor Res. 2003; 37:138-62. Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M, Mao JT. PMID: 12795053.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    224. Intratumoral therapy with cytokine gene-modified dendritic cells in murine lung cancer models. Methods Mol Med. 2003; 75:711-22. Sharma S, Yang SC, Batra RK, Dubinett SM. PMID: 12407774.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    225. Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer. Methods Mol Med. 2003; 75:723-36. Sharma S, Huang M, Dohadwala M, Pold M, Batra RK, Dubinett SM. PMID: 12407775.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    226. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol. 2002 11; 42(S1):71S-81S. Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. PMID: 12412839.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    227. Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem. 2002 Dec 27; 277(52):50828-33. Dohadwala M, Batra RK, Luo J, Lin Y, Krysan K, Pold M, Sharma S, Dubinett SM. PMID: 12393872; PMCID: PMC1471886.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    228. Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. Clin Cancer Res. 2002 Jun; 8(6):1915-23. Bernal RM, Sharma S, Gardner BK, Douglas JT, Bergelson JM, Dubinett SM, Batra RK. PMID: 12060636.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    229. Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood. 2002 Apr 15; 99(8):2869-79. Basak SK, Harui A, Stolina M, Sharma S, Mitani K, Dubinett SM, Roth MD. PMID: 11929777.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    230. IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest. 2002 Apr; 109(7):931-7. Huang M, Sharma S, Zhu LX, Keane MP, Luo J, Zhang L, Burdick MD, Lin YQ, Dohadwala M, Gardner B, Batra RK, Strieter RM, Dubinett SM. PMID: 11927620; PMCID: PMC150933.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    231. Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta. Biochem Biophys Res Commun. 2002 Jan 11; 290(1):91-6. Gardner B, Zu LX, Sharma S, Liu Q, Makriyannis A, Tashkin DP, Dubinett SM. PMID: 11779138.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    232. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication. Hum Gene Ther. 2000 Jan 01; 11(1):53-65. Miller PW, Sharma S, Stolina M, Butterfield LH, Luo J, Lin Y, Dohadwala M, Batra RK, Wu L, Economou JS, Dubinett SM. PMID: 10646639.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    233. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 1997 Jan-Feb; 4(1):17-25. Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, Dubinett S, Glaspy J, McBride WH, Economou JS. PMID: 9012447.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    234. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther. 1996 Sep-Oct; 3(5):302-13. Sharma S, Wang J, Huang M, Paul RW, Lee P, McBride WH, Economou JS, Roth MD, Kiertscher SM, Dubinett SM. PMID: 8894249.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    235. Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7. J Natl Cancer Inst. 1995 Apr 19; 87(8):593-7. Dubinett SM, Huang M, Dhanani S, Economou JS, Wang J, Lee P, Sharma S, Dougherty GJ, McBride WH. PMID: 7752257.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    236. Cytokine immunotherapy of non-small cell lung cancer. Reg Immunol. 1993 May-Aug; 5(3-4):232-43. Dubinett SM, Kradin RL. PMID: 8240940.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    237. Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy. Immunol Invest. 1993 Feb; 22(1):13-23. Dubinett SM, Patrone L, Huang M, Markowitz J, McBride WH, Economou JS, Tobias J, Kelley D, Yan D, Seelig M. PMID: 8440522.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    238. Effects of tumor necrosis factor-alpha on peroxidation of plasma lipoprotein lipids in experimental animals and patients. Blood. 1992 Dec 15; 80(12):3217-26. McDonagh J, Fossel ET, Kradin RL, Dubinett SM, Laposata M, Hallaq YA. PMID: 1467525.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    239. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res. 1992 Jul 15; 52(14):3931-7. McBride WH, Thacker JD, Comora S, Economou JS, Kelley D, Hogge D, Dubinett SM, Dougherty GJ. PMID: 1617669.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    240. Cytokine administration alters the distribution of activated lymphocytes to the lung. Pathobiology. 1991; 59(6):372-7. Dubinett SM, Callahan RJ, Xia WJ, Ahmad M, Strauss HW, Kradin RL. PMID: 1930689.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    241. Adoptive immunotherapy of murine pulmonary metastases with interleukin 2 and interferon-gamma. Am J Respir Cell Mol Biol. 1989 Nov; 1(5):361-9. Dubinett SM, Kurnick JT, Kradin RL. PMID: 2517774.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    242. Efficacy of adjuvant interleukin-2 after excision of BALB/c fibrosarcomas. Surgery. 1989 Aug; 106(2):120-5. Gallagher WJ, Dubinett SM, Hoover HC, Kradin RL. PMID: 2788315.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    243. Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet. 1989 Mar 18; 1(8638):577-80. Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinett SM, Pinto CE, Gifford J, Davidson E, Grove B, Callahan RJ, et al. PMID: 2564111.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCellsCTClinical Trials
    244. Adoptive immunotherapy with IL-2 results in the loss of delayed-type hypersensitivity responses and the development of immediate hypersensitivity to recall antigens. Clin Immunol Immunopathol. 1989 Feb; 50(2):184-95. Kradin RL, Kurnick JT, Preffer FI, Dubinett SM, Dickersin GR, Pinto C. PMID: 2783665.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    245. Treatment of patients with advanced cancer using tumor-infiltrating lymphocytes and interleukin 2. Transplant Proc. 1988 Apr; 20(2):336-8. Kradin R, Dubinett S, Mullin J, Boyle L, Strauss HW, Bourgoin PM, Preffer FI, Kurnick J. PMID: 3259036.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    246. Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother. 1987; 24(1):76-85. Kradin RL, Boyle LA, Preffer FI, Callahan RJ, Barlai-Kovach M, Strauss HW, Dubinett S, Kurnick JT. PMID: 3493073.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    Steven's Networks
    Concepts (818)
    Derived automatically from this person's publications.
    _
    Co-Authors (131)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _